BenevolentAI (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery.


BenevolentAI is a leading developer of advanced artificial intelligence technologies that unlock the value of multimodal data, surface novel insights, and accelerate biomedical discovery

Through the combined capabilities of its AI platform, its scientific expertise, and wet-lab facilities, the Company is developing an inhouse drug pipeline of high-value assets. The Company is headquartered in London, with a research facility in Cambridge (UK) and a further office in New York.

Our pipeline

Reports and presentations

Date and title 21 Sep 2023
Interim results for the six months ended 30 June 2023
Presentation View
Webcast Watch

All reports and presentations


All announcements

Annual Report

Annual Report 2022

Financial calendar

No upcoming events.

Full calendar

Investors - Email Alerts.jpg


Get alerts for our announcements

Investor events, conference attendance and annual reporting.

Sign up